• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Activity of cefepime, ceftazidime, and ceftizoxime against mutants of Enterobacteriaceae and Pseudomonas aeruginosa derepressed for class I beta-lactamase.

作者信息

Knapp C C, Washington J A

机构信息

Cleveland Clinic Foundation, Ohio 44195-5140.

出版信息

J Antimicrob Chemother. 1989 Dec;24(6):1011-2. doi: 10.1093/jac/24.6.1011.

DOI:10.1093/jac/24.6.1011
PMID:2516083
Abstract
摘要

相似文献

1
Activity of cefepime, ceftazidime, and ceftizoxime against mutants of Enterobacteriaceae and Pseudomonas aeruginosa derepressed for class I beta-lactamase.头孢吡肟、头孢他啶和头孢唑肟对I类β-内酰胺酶去阻遏的肠杆菌科细菌和铜绿假单胞菌突变体的活性。
J Antimicrob Chemother. 1989 Dec;24(6):1011-2. doi: 10.1093/jac/24.6.1011.
2
Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.FK037、头孢匹罗、头孢他啶和头孢吡肟对氨基糖苷类敏感及耐药铜绿假单胞菌和假单胞菌属的抗菌活性比较
Chemotherapy. 1994;40(6):391-8. doi: 10.1159/000239298.
3
Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.新型头孢菌素头孢利定、头孢吡肟和头孢匹罗对头孢他啶或亚胺培南耐药铜绿假单胞菌的体外活性比较
J Antimicrob Chemother. 1992 Nov;30(5):633-41. doi: 10.1093/jac/30.5.633.
4
Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa.铜绿假单胞菌中苯唑西林酶介导的对头孢吡肟耐药及对头孢他啶敏感
Antimicrob Agents Chemother. 2001 Jun;45(6):1615-20. doi: 10.1128/AAC.45.6.1615-1620.2001.
5
Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime.新型广谱头孢菌素FK-037的抗菌活性。与头孢吡肟和头孢他啶的国际体外比较。
Diagn Microbiol Infect Dis. 1994 Mar;18(3):167-73. doi: 10.1016/0732-8893(94)90087-6.
6
Activity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015-16.2015-2016 年英国分离的产 ESBL 肠杆菌科细菌和铜绿假单胞菌对头孢他啶/阿维巴坦的活性。
J Antimicrob Chemother. 2018 Mar 1;73(3):648-657. doi: 10.1093/jac/dkx438.
7
beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
J Antimicrob Chemother. 1991 Aug;28(2):209-19. doi: 10.1093/jac/28.2.209.
8
Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa by using cefepime, ceftazidime, or ceftobiprole.使用头孢吡肟、头孢他啶或头孢托罗匹酯对铜绿假单胞菌一步 AmpC 或外排突变体进行差异选择。
Antimicrob Agents Chemother. 2010 Oct;54(10):4092-7. doi: 10.1128/AAC.00060-10. Epub 2010 Jul 6.
9
WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases.WCK 5222（头孢吡肟/齐地卡南）针对产生具有临床相关性β-内酰胺酶的革兰氏阴性菌的抗菌活性测试。
J Antimicrob Chemother. 2017 Jun 1;72(6):1696-1703. doi: 10.1093/jac/dkx050.
10
Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime.铜绿假单胞菌对头孢吡肟、头孢他啶和头孢噻肟的体外耐药频率。
Antimicrob Agents Chemother. 1988 Sep;32(9):1443-5. doi: 10.1128/AAC.32.9.1443.

引用本文的文献

1
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.亚胺培南、美罗培南、头孢吡肟和头孢他啶对产碳青霉烯水解β-内酰胺酶的阴沟肠杆菌所致实验性肺炎大鼠的疗效。
Antimicrob Agents Chemother. 2000 Apr;44(4):885-90. doi: 10.1128/AAC.44.4.885-890.2000.
2
Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.头孢吡肟、头孢他啶和亚胺培南单独使用或与阿米卡星联合使用对由头孢他啶敏感或耐药的阴沟肠杆菌菌株引起的实验性肺炎大鼠的疗效。
Antimicrob Agents Chemother. 1998 Dec;42(12):3304-8. doi: 10.1128/AAC.42.12.3304.
3
Cefepime clinical pharmacokinetics.头孢吡肟的临床药代动力学。
Clin Pharmacokinet. 1993 Aug;25(2):88-102. doi: 10.2165/00003088-199325020-00002.
4
Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime.FK-037、头孢吡肟、头孢曲松、头孢他啶和头孢呋辛体外活性的多中心比较。
Antimicrob Agents Chemother. 1993 Aug;37(8):1696-700. doi: 10.1128/AAC.37.8.1696.
5
Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics.在常见大肠杆菌宿主背景中表达的β-内酰胺酶检测板的开发，用于评估新型β-内酰胺类抗生素。
Antimicrob Agents Chemother. 1995 Feb;39(2):308-13. doi: 10.1128/AAC.39.2.308.
6
Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria.SCE-2787、头孢吡肟与氨基糖苷类药物联合对医院革兰氏阴性菌的作用
Infection. 1991 May-Jun;19(3):186-9. doi: 10.1007/BF01643250.
7
Future directions in antimicrobial chemotherapy.抗菌化疗的未来发展方向。
Pharm Weekbl Sci. 1992 Aug 21;14(4A):229-44. doi: 10.1007/BF01962545.